Results 191 to 200 of about 41,188 (289)

Low-dose methotrexate in myeloproliferative neoplasm models

Haematologica, 2017
Kavitha Chinnaiya, Michelle A. Lawson, Sally Thomas, Marie-Therese Haider, Jenny Down, Andrew D. Chantry, David Hughes, Antony Green, Jon R. Sayers, John A. Snowden, Martin P. Zeidler   +10 more
doaj   +1 more source

A Massive Haemothorax Due to Pleural Extramedullary Haematopoiesis in a Patient With Myelodysplastic Syndrome/Myeloproliferative Neoplasm. [PDF]

Cureus
Theeb M, Idris S, Sheaff M, McCloskey K.
europepmc   +1 more source

Clinical and disease characteristics from REVEAL at time of enrollment (baseline): Prospective observational study of patients with polycythemia vera in the United States [PDF]

, 2018
Boccia, Ralph V, Colucci, Philomena, Grunwald, Michael R, Mesa, Ruben, Oh, Stephen T, Paranagama, Dilan, Parasuraman, Shreekant, Stein, Brady L   +7 more
core   +1 more source

Genetic insights into myeloproliferative neoplasms and unusual sites thrombosis [PDF]

Erika Morsia, Paola Ranalli, Stefano Baldoni, Stefania Mancini, Sonia Morè, Chiara Cantò, Dorela Lame, Gaetano La Barba, Antonella Poloni, Serena Rupoli, Mauro Di Ianni   +10 more
openalex   +1 more source

Gender and Vascular Complications in the JAK2 V617F-Positive Myeloproliferative Neoplasms [PDF]

, 2011
Brady L. Stein, Alfred Rademaker, Jerry L. Spivak, Alison R. Moliterno   +3 more
openalex   +1 more source

The Immunological Consequences of Clonal Hematopoiesis in Heart Failure

Immunological Reviews, Volume 337, Issue 1, January 2026.
ABSTRACT Inflammation is increasingly recognized as a central driver of heart failure (HF), particularly in older adults, yet the underlying immune mechanisms remain diverse and incompletely understood. Clonal hematopoiesis (CH), defined by the expansion of somatically mutated hematopoietic clones, has emerged as a risk factor for the development of ...
Megan A. Evans, Kenneth Walsh
wiley   +1 more source

Myeloproliferative neoplasm subtypes have distinct impact on risk of incident osteoporosis and osteoporotic fractures. [PDF]

Blood Adv
Lee MH, Wang Y, Cronin A, Tramontano AC, Weeks LD, Hobbs GS.   +5 more
europepmc   +1 more source

Diagnostic reassessment in myeloproliferative neoplasms: the value of functional iron parameters and JAK2 allelic burden [PDF]

Rita González-Resina, Sara España-Fernández de Valderrama, Ángeles Montañés, Axel Rüfer, Gonzalo Caballero   +4 more
openalex   +1 more source

The JAK2V617F and CALR mutations and risk of cancer, cardiovascular diseases, and all‐cause mortality

Journal of Internal Medicine, Volume 299, Issue 1, Page 79-94, January 2026.
Abstract Background Clonal hematopoiesis (CH) is associated with adverse outcomes. We hypothesized that CH (JAK2V617F and CALR) is associated with cancer, vascular disease, and all‐cause mortality, even at a variant allele frequency (VAF) <1%. Methods We screened 19,832 individuals from the Danish General Suburban Population Study for JAK2V617F and ...
Morten Kranker Larsen, Vibe Skov, Lasse Kjær, Christina Schjellerup Eickhardt‐Dalbøge, Trine Alma Knudsen, Marie Hvelplund Kristiansen, Anders Lindholm Sørensen, Sabrina Cordua, Troels Wienecke, Mette Grymer Jensen, Morten Andersen, Johnny T. Ottesen, Johanne Gudmand‐Høyer, Jordan Andrew Snyder, Henrik Enghusen Poulsen, Thomas Stiehl, Christina Ellervik, Hans Carl Hasselbalch   +17 more
wiley   +1 more source

Concurrent Presentation of Pure Red Cell Aplasia and Myeloproliferative Neoplasm, Unclassifiable With JAK2 and MPL Mutations. [PDF]

Case Rep Hematol
Li Q, Tan L, Wang X, Fan Q.
europepmc   +1 more source